Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Net Margin (2016 - 2026)

OptimizeRx's Net Margin history spans 16 years, with the latest figure at 15.57% for Q4 2025.

  • On a quarterly basis, Net Margin rose 1581.0% to 15.57% in Q4 2025 year-over-year; TTM through Dec 2025 was 4.69%, a 2652.0% increase, with the full-year FY2025 number at 4.69%, up 2652.0% from a year prior.
  • Net Margin hit 15.57% in Q4 2025 for OptimizeRx, up from 2.99% in the prior quarter.
  • Over the last five years, Net Margin for OPRX hit a ceiling of 15.57% in Q4 2025 and a floor of 49.2% in Q1 2023.
  • Historically, Net Margin has averaged 15.17% across 5 years, with a median of 13.79% in 2023.
  • Biggest five-year swings in Net Margin: tumbled -3973bps in 2023 and later surged 4581bps in 2025.
  • Tracing OPRX's Net Margin over 5 years: stood at 3.07% in 2021, then crashed by -154bps to 1.66% in 2022, then tumbled by -2396bps to 41.38% in 2023, then soared by 99bps to 0.24% in 2024, then skyrocketed by 6551bps to 15.57% in 2025.
  • Business Quant data shows Net Margin for OPRX at 15.57% in Q4 2025, 2.99% in Q3 2025, and 5.25% in Q2 2025.